Photocure ASA: Presentation of the fourth quarter and full year 2016 results
07 févr. 2017 05h33 HE
|
Photocure ASA
Photocure will present its fourth quarter and full year 2016 report on Wednesday 15 February 2017 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and representatives...
Photocure Completes Enrollment in US Market expansion study of Blue Light Flexible Cystoscopy (BLFC) with Cysview ®
03 févr. 2017 02h00 HE
|
Photocure ASA
Oslo, Norway, February 3, 2017 Photocure ASA (OSE: PHO), announced today that it has completed enrollment in its Phase 3 study with BLFC with Cysview in patients with Non Muscle Invasive Bladder...
Photocure to present at investor meetings in San Francisco
09 janv. 2017 03h53 HE
|
Photocure ASA
Oslo, Norway, January 9, 2017Photocure ASA (OSE: PHO) management is this week conducting investor meetings in San Francisco (US) in connection with the J.P. Morgan healthcare conference. ...
Photocure ASA: US registry shows that Blue Light Cystoscopy (BLC) with Cysview®/Hexvix® leads to improved detection and classification of bladder cancer
05 déc. 2016 02h00 HE
|
Photocure ASA
Oslo, Norway, December 5, 2016 Photocure ASA (PHO-NO) announced today new data from a prospective multicenter real world study that included 338 patients, 415 BLC procedures and 1060 lesions from...
Photocure ASA: Share capital increase registered
30 nov. 2016 09h57 HE
|
Photocure ASA
Reference is made to the announcement on 24 November 2016 in respect of a capital increase of 12 481 new shares following exercise of employee share options in the company. The share capital...
Photocure ASA: Blue Light Cystoscopy (BLC) with Cysview®/Hexvix® decreases the risk of progression and recurrence in bladder cancer
28 nov. 2016 02h00 HE
|
Photocure ASA
Oslo, Norway, November 28th, 2016 Photocure ASA announced the publication of The Comparative effectiveness of fluorescence cystoscopy versus white light cystoscopy (WLC) for initial diagnosis or...
Photocure ASA: Update on management shareholdings and exercise of employee share
24 nov. 2016 02h02 HE
|
Photocure ASA
Update on management shareholdings and exercise of employee share options in Photocure ASA ("the Company"). Oslo, Norway, 24 November 20161. Participants in the Photocure's share option program...
Photocure ASA: Strong recommendations for Blue Light Cystoscopy with Hexvix® in new French Guidelines
21 nov. 2016 05h32 HE
|
Photocure ASA
Oslo, Norway, November, 21 2016: Photocure ASA (OSE:PHO) announced today that new 2016 French National Guidelines for the management of Bladder Cancer includes its Blue Light Cystoscopy (BLC) with...
Photocure ASA: Results for third quarter 2016
15 nov. 2016 01h32 HE
|
Photocure ASA
Oslo, Norway, 15 November 2016: Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in cancer and dermatology, reported a revenue growth of 17 % to NOK...
Photocure ASA: Presentation of the third quarter 2016 results
09 nov. 2016 07h18 HE
|
Photocure ASA
Photocure will present its third quarter report on Tuesday 15 November 2016 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and representatives from the company will...